Secondly, in most studies that have screened human sera by immunoblot analysis (5, 14, 16, 29) , antibodies bound the protein that has an apparent migration of 41-kDa and has been assumed, but not proven, to be flagellin.
In our efforts to develop a better serological test for Lyme borreliosis, we have cloned a 39-kDa nonflagellar antigen (P39) of B. burgdorferi in Escherichia coli. This antigen is immunoreactive with most sera from human patients with Lyme borreliosis and may represent an antigenic component of the spirochete that at times has been mistaken for the 41-kDa flagellin.
MATERIALS AND METHODS
Bacterial strains. B. burgdorferi strains used in this study (Table 1 ) have been previously described or were kindly provided by John Anderson (Connecticut Agriculture Experiment Station, New Haven), Alan MacDonald (Southampton Hospital, Southampton, N.Y.), and Glenna Teltow and Julie Rawlings (Medical Entomology Section, Bureau of Laboratories, Texas Department of Health, Austin). The five strains representing Borrelia hermsii (HS1), Borrelia coriaceae (Co53), Borrelia parkeri, Borrelia turicatae, and Borrelia anserina have been described previously (35) . Borrelia organisms were cultured at 32°C in BSK-II medium as previously described (2) .
DNA purifications. Total DNA was purified from 500-ml stationary-phase borrelial cultures by a modification of a previously described method (4) . Cells were recovered by centrifugation, washed in 20 ml of phosphate-buffered saline plus 5 mM MgCl2, and suspended in 2.4 ml of TES (50 mM Tris, pH 8.0; 50 mM EDTA; 15% [wt/vol] sucrose). Lysozyme was added to a final concentration of 1 mg/ml, and then the cell suspension was left on ice for 10 min. Cells were lysed by addition of 3 Recombinant plasmid pSPR33 was isolated from E. coli for mapping studies from 500-ml cultures and purified as previously described (37) , except that two consecutive dyebuoyant density gradients were performed (30) in a VTi8O rotor (Beckman Instruments, Inc., Fullerton, Calif.) at 70,000 rpm for 4 h at 18°C. The supercoiled circular plasmid portion was diluted with 2 volumes of water after removal of the ethidium bromide and then ethanol precipitated. The plasmid DNA was then suspended in a minimal volume of TE.
Agarose gel electrophoresis and Southern blot analysis.
Undigested total DNA was electrophoresed in 0.4% agarose gels (12 V for 16 h). Southern blot procedures, including the transfer of DNA from agarose gels to nitrocellose, highstringency hybridization (which permitted 10% base pair mismatch), and autoradiography, were as previously described (38) , except that the prehybridization and hybridization buffers and temperatures were as described by Schwan et al. (35 with E. coli XL1-blue cells (Stratagene) collected from 500-ml cultures and incubated with rotation at 37°C for 4 h. The bacteria were removed by centrifugation in a VTi80 rotor at 40,000 rpm for 30 min. This process was repeated twice, and adsorbed sera were then filtered through a sterile, 0.22-,um-pore-size filter (Millipore Corp., Bedford, Mass.) and stored at -20°C. Anti-pSPR33 and anti-E. coli sera were used at dilutions of 1:500 and 1:50, respectively. Tissue culture supernatants were the source of monoclonal antibodies H5332 (9), H5TS (8), and H9724 (6) and were used at a dilution of 1:100.
Human syphilitic sera were kindly provided by Wayne Hogrefe and Jane Markley (Hillcrest Biologicals, Cypress, Calif.), amyotrophic lateral sclerosis sera were provided by Jeffrey Smith (ALS Clinic, Mount Sinai Medical Center, New York, N.Y.) and Alan MacDonald, and relapsing fever sera were collected from patients from Oregon and Washington. Normal sera were obtained from staff and laboratory personnel at Rocky Mountain Laboratories. Human Lyme borreliosis sera were provided by Alan MacDonald and were collected from patients clinically diagnosed with Lyme borreliosis from Long Island, N.Y.
Immunofluorescence assay (IFA) titers of Lyme borreliosis and relapsing fever sera were determined as previously described (11) . B. burgdorferi B31 and B. hermsii HS1, respectively, were used as the antigens in the IFAs.
Immunoblot analyses of whole-cell lysates were performed essentially as previously described elsewhere (34) except that cells were prepared as follows. Cells were recovered from liquid cultures by centrifugation (8,000 x g for 5 min) and suspended in phosphate-buffered saline to give an optical density of 0.2 at 600 nm. Cells from 2 ml of this suspension were recovered by centrifugation and suspended in 100 4 min, and 20 ,ul was loaded onto a 12.5% SDS-polyacrylamide gel. Gel electrophoresis, immunoblotting, and detection of bound antibody with 125I protein A have been described previously (34) .
Immune electron microscopy. Intact flagella were isolated from cultures of B. burgdorferi Sh-2-82 as previously described (6). Strain Sh-2-82 had been passaged in vitro six times. Flagella were adsorbed onto grids, and bound antibody was detected as described elsewhere (8) . Tissue culture supernatants were the source of the flagellum-specific monoclonal antibody H9724 and were diluted 1:100. Anti-pSPR33 antiserum was used at a dilution of 1:50.
RESULTS Cloning and genetic analysis of Borrelia DNA. To identify B. burgdorferi antigens that induce an antibody response during the course of infection, a DNA library of B. burgdorferi containing EcoRI fragments was constructed in E. coli with the X expression vector XZAPII. The library was screened for Borrelia antigens with a convalescent-phase serum from a human Lyme borreliosis patient (IFA titer, 1:1,024). Positive clones were detected at a frequency of 5%, and one was plaque purified to yield a homogeneous bacteriophage preparation. Excision of the cloned fragment from the purified phage produced the phagemid portion containing a 6.3-kilobase-pair (kb) EcoRI fragment, designated plasmid pSPR33 (Fig. 1) . The fragment was isolated from an agarose gel, radiolabeled, and shown to hybridize with a similar-size fragment in EcoRI-digested total DNA from six North American B. burgdorferi isolates and one European isolate ( similar isolates indicated that the 6.3-kb fragment hybridized strongly with chromosomal DNA (Fig. 3) . The smeared band in agarose gels that contained heterogenous fragmented DNA and migrated slightly more slowly than the 49-kb linear plasmid from strain Sh-2-82 was assumed to be chromosomal DNA. Total DNA from five additional Borrelia species (B. Antigens similar in size to P28 and P39 were detected by immunoblot (Fig. 4) in cell lysates of B. burgdorferi Sh-2-82, suggesting that P28 and P39 are expressed by this strain. To determine whether the 28-and 39-kDa Borrelia antigens seen in whole cell lysates were identical to the gene products P28 and P39, respectively, antiserum generated to cells carrying pSPR33 (anti-pSPR33 serum) was incubated with Westernblotted whole-cell lysates of 1 European and 19 North American B. burgdorferi isolates and compared with a lysate of E. coli producing P28 and P39 (Fig. 5) . All of the 20 Borrelia isolates expressed a 39-kDa antigen that comigrated with P39. A 28-kDa antigen was also detected, but considerably less antibody bound this antigen than that which bound P39. P39 produced by pSPR33 also reacted with sera from five white-footed mice (Peromyscus leucopus) experimentally infected with B. burgdorferi Sh-2-82 but did not react with the preimmune sera from these animals or with sera from mice infected only with E. coli (data not shown). Other Borrelia species did not produce detectable amounts of P28, P39, or any other antigenically related components under the conditions employed (Fig. 5) encode P28 and P39 (Fig. 2) , show that P28 and P39 are antigens specific to B. burgdorferi. Furthermore, antipSPR33 did not react with the B. burgdorferi antigens OspA (31 kDa), OspB (34 kDa), or the 41-kDa flagellin ( Fig. 5 and  6 ), suggesting that these antigens are immunologically unrelated to P28 and P39. To confirm this, we showed that the monoclonal antibodies H5332, H5TS (data not shown), and H9724 (Fig. 6) , which bind specifically to OspA (9), OspB (8) , and flagellin (6), respectively, did not bind to P28 or P39 produced by either pSPR33 or strain Sh-2-82. The specificity of monoclonal antibody H9724 for Borrelia flagellin is evident in Fig. 6 , as it bound only a 41-kDa band in the B. burgdorferi profile and a 39-kDa band, which corresponds to its flagellin (6) , in the B. hermsii profile. Furthermore, as revealed by electron microscopy and colloidal gold staining, monoclonal antibody H9724 bound to endoflagella from B.
burgdorferi, whereas anti-pSPR33 did not (data not shown).
Immunoreactivity of Lyme borreliosis sera with cloned
Borrelia antigens. To test the possibility that P28 and P39 are recognized by the sera of Lyme borreliosis patients, 94 serum specimens collected from patients clinically diagnosed as having Lyme borreliosis were tested for reactivity with cloned P28 and P39 at a dilution of 1:100. Whole-cell lysates were electrophoresed in SDS-PAGE gels and Western blotted. The nitrocellulose was cut into equal strips (five per gel) such that each strip contained lanes for E. coli carrying pSPR33, E. coli carrying only the vector, and B. burgdorferi Sh-2-82. Each strip was incubated with a different human serum, except one strip from each gel was incubated with anti-pSPR33 serum. This strip served as a marker for the positions of P28 and P39. AUl of 33 serum specimens with IFA titers of .1:256 (100%), 13 of 17 serum specimens (76%) with IFA titers of 1:128, and 14 of 44 serum specimens (32%) with titers of <1:64 reacted with P39 ( Table  2) . Examples of immunoblots for human sera reacting with P39 are shown in Fig. 7 (arrow 1) . A strongly reacting 58-to 64-kDa band was observed in the B. burgdorferi profile (Fig.  7, band A) for all sera that reacted with P39, but since anti-pSPR33 serum did not react to a band in this region of the gel (Fig. 5) , P39 and the 58-to 64-kDa protein(s) are presumably unrelated. Although P28 appeared to react strongly to some sera (Fig. 7B, band B) , for other, less reactive sera, it was not clear if the sera reacted to P28 or to some other protein. This was because these sera also reacted with comigrating E. coli antigens that were detected with a longer autoradiographic exposure (Fig. 7A, band B) . Therefore, although it is not clear to what extent P28 actually reacts with human Lyme borreliosis sera, it appears that antibody to P39 was detected in 100% of all sera that had IFA titers of-1:256. Notably, many sera reactive to P39 did not appear to react with the 41-kDa flagellin (Fig. 7) . Yet, all sera that reacted within the 41-kDa band also reacted with P39, although the latter antigen was often obscured in B. burgdorferi profiles by the signal associated with the 41-kDa band. In view of this, antibody to P39 could be mistaken as antibody to flagellin in tests of human sera by immunoblot with whole-cell lysates of B. burgdorferi. Because P39 was shown to be specific to B. burgdorferi by immunoblot, it is not surprising that control sera, which included sera from 5 amytrophic lateral sclerosis patients, 5 syphilitic patients, 5 relapsing fever patients, and 10 normal individuals who showed no symptoms of clinical disease, did not react to the 10 humnan lIyme borreliosis sera and their reactivity with P28 'nd P39. Whole-cell lysates of B. burgdorferi Sh-2-82 (lanes 1), E. coli carrying pSPR33 (lanes 2), and E. coli carrying only vector (lanes 3) were immunoblotted with human Lyme borreliosis serae (NY). Anti-pSPR33 reactivity, which identified the position of the btand corresponding to P39, is not shown. IFA Lyme borreliosis liters for eaich human serum are indicated below their designalions. Aultor+Cadliographs exposed for 5 h (A) represented sera having weaker reactivity than those exposed for 0.5 h (B). Arrows: 1, P39: 2, a 41-kD)a antigen. Band B corresponds to the position of P28, and bald A is a 58-to 64-kDa antigen that bound all sera that reacted with P39. Molecular mass markers (in kilodaltons) are indicated on thc right of each panel.
cloned P39 protein at a dilution of 1:50 (Table 3) . Immunoblot findings for the syphilitic sera are shown in Fig. 8 . These data suggest that P39 has antigenic specificity for sera collected from patients with Lyme borreliosis. This is despite the fact that both the syphilitic and relapsing fever sera tested had significantly high IFA Lyme borreliosis titers (Table 3) and therefore most likely contained cross-reacting antibodies directed at other B. burgdoiferi antigens. (3) . Although antibodies to these antigens have been detected in Lyme borreliosis sera, their use as serodiagnostic antigens can be questioned due to their lack of antigenic specificity (22) or antigenic stability (7, 8, 33) . We describe a 39-kDa antigen (P39) that is specific to B. burgdorferi and strongly serologically reactive. Monoclonal antibodies H5332, H5TS, and H9724 permitted the identification of the bands in SDS-PAGE profiles that corresponded to OspA, OspB, and flagellin, respectively. Thus, the position of the band corresponding to P39 could be distinguished from these three antigens, including the closely migrating flagellin. Polyclonal antisera to P39 did not react with these other antigens in immunoblots ( Fig. 5 and 6 ) and did not bind to endoflagella from B. burgdorferi in electron microscopy studies. These observations indicate that P39 is unrelated to OspA, OspB, or endoflagella.
The specificity with which P39 bound antibody from Lyme borreliosis sera was demonstrated by its nonreactivity with sera from several control groups, including syphilitic and relapsing fever patients. This was despite the fact that these sera had relatively high concentrations of antibodies that cross-reacted with whole cells of B. burgdorferi in IFAs (Table 3 ). Many of these antibodies were probably binding to epitopes common to spirochetal flagellins (Fig. 8) , illustrating the problem of cross-reactivity encountered when endoflagella (22) be species specific and reactive with Lyme borreliosis sera. P28, however, is present in less concentration or is less immunogenic than P39, or antibodies to P28 have low avidity or affinity, since P28 reacted relatively weakly with antipSPR33 and Lyme borreliosis sera. Assuming P28 is a distinct antigen and has a unique genetic determinant, then this is the first report describing the genetic linkage of two chromosomally encoded antigens expressed by B. burgdorferi. The significance, if any, of this linkage is not known, but the genes encoding P28 and P39 may be coregulated or form part of an operon similar to that described for the genes encoding OspA and OspB (23, 24) . Notably, anti-pSPR33 antiserum reacted strongly to a band with a molecular mass less than 28-kDa in the E. coli-plus-pSPR33 profile ( Fig. 5  and 6 ) that was considerably less reactive in the E. coliplus-vector profile. The stronger signal may correspond to a third recombinant antigen expressed by pSPR33, or it may merely reflect variability in the expression of an E. coli antigen. The absence of a similar-size antigen in B. burgdorferi and the fact that cultures of E. coli carrying pSPR33 do not always produce profiles showing the strongly reactive band (data not shown) favor the latter possibility. Numerous studies have evaluated antigenic components of B. burgdorferi for their reactivities with Lyme borreliosis sera by Western blotting bacterial whole-cell lysates (2, 5, 14, 16, 29) . Yet, the presence of P39, which we show reacts with a significant percentage of human Lyme borreliosis sera, has not been previously described. Although several reports (19, 26) have noted antibodies in Lyme borreliosis sera reactive with a 39-kDa band, the frequency with which they were detected was considerably lower than what we report for anti-P39 antibodies. This may, in part, be because anti-P39 antibodies are best detected with the recombinant P39 protein rather than with whole-cell lysates of B. burgdorferi. It is also possible that the human sera examined in our study represent a group of Lyme borreliosis patients distinct from those used in other studies or that the presence of P39 was masked by the 41-kDa band corresponding to flagellin in many studies. The large number of sera tested in our study makes the former possibility unlikely. However, although the clear separation of P39 from the flagellin band by SDS-PAGE was demonstrated in this study, the separation of these two antigens may not always be evident and may explain why P39 has not been observed in some studies. In addition, anti-P39 antibodies may have been mistaken for anti-flagellin antibodies, as many of the P39-reactive Lyme borreliosis sera failed to react with flagellin (Fig. 7) . Thus, anti-P39 but not anti-flagellin antibodies were present in these Lyme borreliosis sera. The possibilities that antibodies raised to the flagellin of B. burgdorferi during infection are not as prevalent in Lyme borreliosis sera as first thought and that P39 is a more immunodominant antigen will need to be examined more closely.
